Company Ticker News July 13, 2021Biogen, InnoCare Collaborate On Multiple Sclerosis Candidate 0 0 Share
Company Ticker News July 11, 2021Late-Stage Clinical Study Readouts Biotech Investors Should Watch 0 0 Share
Company Ticker News July 9, 2021FDA calls for investigation into its contacts with Alzheimer's drug maker 0 0 Share
Company Ticker News July 9, 2021FDA Requests Probe Into Staff Interactions With Biogen Ahead Of Aduhelm Approval 0 0 Share
Company Ticker News July 9, 2021Biogen stock falls after FDA calls for federal investigation into Alzheimer's drug approval 0 0 Share
Company Ticker News July 9, 2021Biogen stock falls as FDA may investigate Alzheimer's drug approval process 0 0 Share
Company Ticker News July 9, 2021Should Biogen Worry About a Congressional Investigation Into Its Alzheimer's Disease Drug? 0 0 Share
Company Ticker News July 8, 2021FDA Narrows Label To Recommend Use Of Biogen's Aduhelm In Mild Alzheimer's Patients 0 0 Share
Company Ticker News July 8, 2021Biogen updates label for Alzheimer's disease drug to say it should be used in people with 'mild' disease 0 0 Share